Anti-oxidation anti-inflammation inhibition of Aβ accumulation reduction of alteration of gut microbiome the combination of inflammatory factors (IL-6 and INF-γ), PCs and SCFA-producing bacteria were expected to be early diagnostic biomarkers for AD. This evidence concerns the gene IL6 and Alzheimer disease.